# PET MRI Radiopharmaceuticals, Detroit

Canonical: https://abierto.us/opportunities/36c25026q1039

- Solicitation number: 36C25026Q1039
- Notice type: Special notice
- Status: Closed. Deadline was September 23, 2026 at 4:00 PM EDT
- Department: Department of Veterans Affairs
- Contracting office: 250-Network Contract Office 10 (36C250)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- First posted: September 21, 2026
- Last posted: September 21, 2026
- SAM.gov: https://sam.gov/workspace/contract/opp/5f5f2c6720874ce99bd8221005200e5c/view

## Description

Special Notice

Page 4 of 4
INTENT TO SOLE SOURCE
The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201. The Department of Veterans Affairs intends to award a sole source, firm-fixed price, 1-year purchase order to Sofie Co., 21000 Atlantic Blvd., Suite 730, Dulles, VA 20166. The associated North American Industry Classification System (NAICS) Code is 325412   Pharmaceutical Preparation Manufacturing, and the Business Size Standard is 1,300 employees.
The contractor will furnish (including packaging, transportation, manifests, and reports) all PET radiopharmaceuticals listed below to the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201 for period of performance October 1, 2026, through September 30, 2027. These are PET radiopharmaceutical supplies used in Nuclear Medicine to perform exams on PET MRI patients.
Product Name
UoM
Est. Annual Quantity
Cu-64 Dotatate (Detectnet) 3-5 mCi
Dose
15
F18 PSMA (Pylarify) 8-10 mCi
Dose
120
F18 Fluorodeoxyglucose (FDG) 8-10 mCi
Dose
200
F18 Neuraceq 8-10 mCi
Dose
20
Pylarify (PSMA) Cancellation Fee
N/A
22

It is the Government s belief that Sofie Co. is the only vendor capable of providing all of these specific radiopharmaceuticals for the Detroit VA. Sources sought notice 36C25026Q0931 was sent out to prospective vendors, with a reply window of August 18, 2026 through August 20, 2026. Responses were received from five contractors, including Sofie Co. Contractor capabilities were reviewed, and although the other contractors could provide some of the required products, Sofie Co. was the only contractor capable of providing all of these specific radiopharmaceuticals required by Detroit VA Nuclear Medicine.
This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Interested persons may identify their interests and capability to respond to this requirement no later than 4:00 PM Eastern Time, Wednesday, September 23, 2025. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government.
Interest/capability statements shall be submitted to James Howard, Contracting Specialist, via e-mail at james.howard3@va.gov. Telephone inquiries will not be accepted.

## Attachments

- [36C25026Q1039.docx](https://sam.gov/api/prod/opps/v3/opportunities/resources/files/cce0950abc4246b3bcd0d029dac9ee8f/download)

## Publications

- September 21, 2026: Special notice, due September 23, 2026 at 4:00 PM EDT. Notice 5f5f2c6720874ce99bd8221005200e5c. https://sam.gov/workspace/contract/opp/5f5f2c6720874ce99bd8221005200e5c/view

## Points of contact

- Contract Specialist, James Howard, james.howard3@va.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/36c25026q1039.
